Correlation of EtCO₂- and P(A-a)O₂-Based Dead Space Calculations in Mechanically Ventilated ICU Patients
CODE-EtA
COmparison of Physiological Dead Space Calculations Using EtCO₂ and P(A-a)O₂ in Mechanically Ventilated ICU Patients: A Prospective Observational Study
1 other identifier
observational
41
1 country
1
Brief Summary
This study aims to evaluate two different methods for calculating physiological dead space in adult patients undergoing invasive mechanical ventilation in the intensive care unit (ICU). Physiological dead space refers to the portion of air that is ventilated but does not participate in gas exchange due to impaired perfusion or ventilation-perfusion mismatch. Traditionally, dead space is calculated using the end-tidal carbon dioxide (EtCO₂) method, which estimates the difference between arterial and exhaled CO₂ values. However, this method may be influenced by circulatory failure or abnormal CO₂ distribution. An alternative method using the alveolar-arterial oxygen gradient \[P(A-a)O₂\] has been proposed, as it may provide a more stable measurement under critical conditions by relying on oxygenation efficiency rather than CO₂ elimination. In this prospective observational study, patients receiving mechanical ventilation in a tertiary ICU will be monitored. Physiological dead space will be calculated using both the EtCO₂-based method and the P(A-a)O₂-based method. Various respiratory and clinical parameters, including arterial blood gases, ventilator settings, and severity scores, will be recorded. The correlation between the two methods will be assessed, and their relationship with ICU mortality will be analyzed. The results of this study may help determine whether the P(A-a)O₂ method can be used as a reliable alternative for estimating dead space in ICU patients and whether it has prognostic value in predicting patient outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 10, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 18, 2025
CompletedFirst Submitted
Initial submission to the registry
April 20, 2025
CompletedFirst Posted
Study publicly available on registry
April 27, 2025
CompletedApril 27, 2025
April 1, 2025
3 months
April 20, 2025
April 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correlation between EtCO₂- and P(A-a)O₂-based dead space calculations
Description: Pearson or Spearman correlation coefficient calculated between dead space values obtained from EtCO₂ (Enghoff modification) and P(A-a)O₂-based gradient methods in mechanically ventilated ICU patients.
Within the first 72 hours of ICU admission
Secondary Outcomes (3)
Association of each dead space method with ICU mortality
From ICU admission until ICU discharge or death
Agreement between EtCO₂- and P(A-a)O₂-based dead space estimates
Within first 3 days of ICU stay
Relationship between dead space values and gas exchange/ perfusion variables
Daily for up to 72 hours
Study Arms (1)
Mechanically Ventilated ICU Patients
Adult patients (≥18 years old) admitted to a tertiary ICU and receiving invasive mechanical ventilation for at least 24 hours. Participants are prospectively monitored with capnographic and arterial blood gas measurements, and physiological dead space is calculated using both EtCO₂- and P(A-a)O₂-based methods. Patients are followed until ICU discharge or death.
Eligibility Criteria
The study population includes adult patients (aged 18 years and older) who are admitted to a tertiary academic intensive care unit and require invasive mechanical ventilation for respiratory failure. Eligible patients must be expected to remain intubated for at least 24 hours and undergo both volumetric capnography and arterial blood gas monitoring. Participants are enrolled prospectively and consecutively based on predefined inclusion and exclusion criteria. Patients with circulatory shock, severe metabolic or respiratory derangements, or technical limitations interfering with capnographic measurement are excluded. The study represents a critically ill cohort commonly encountered in ICU practice.
You may qualify if:
- Age ≥ 18 years
- Admission to the intensive care unit (ICU)
- Receiving invasive mechanical ventilation
- Expected ICU stay ≥ 24 hours
- Availability of both arterial blood gas and volumetric capnography measurements
- Central venous cathater for central venous blood analyses
- Informed consent obtained from legal representative
You may not qualify if:
- Refusal of participation by the patient or legal surrogate
- Hemoglobin \< 7 g/dL
- PaCO₂ \> 70 mmHg
- Lactate \> 4 mmol/L
- Capillary refill time \> 3 seconds
- Mean arterial pressure (MAP) \< 65 mmHg
- Mottling score ≥ 2
- PaCO₂ - PcCO₂ gradient \> 8 mmHg
- pH \< 7.20
- Body temperature \> 38°C
- BMI \> 40 kg/m²
- VCO₂ \> 4 mL/kg/min
- Technical limitations preventing accurate capnographic monitoring
- Patients who are extubated, transferred, or deceased within the first 24 hours
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Karadeniz Technical University Faculty of Medicine, Department of Chest Diseases, Intensive Care Unit
Trabzon, 61080, Turkey (Türkiye)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, Assist Prof.
Study Record Dates
First Submitted
April 20, 2025
First Posted
April 27, 2025
Study Start
January 5, 2025
Primary Completion
April 10, 2025
Study Completion
April 18, 2025
Last Updated
April 27, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to ethical and confidentiality considerations, and because no public data-sharing plan has been established for this study.